AI-Driven Variant Classification, VUS Re-Analysis & Genomic Data Analytics Unified in One Platform
Consolidate your genomic, clinical, and phenotypic data into a governed genomic data management platform - then apply AI-driven variant classification, automated VUS interpretation, and cohort-level re-analysis to turn that data into clinical reports faster and with measurable reduction in VUS rates.
What the AI Genomic Data & Analytics Platform Does
Capabilities that turn fragmented genomic data into a governed, AI-powered interpretation engine - designed for clinical labs, precision medicine programmes, and pharma R&D teams running large-scale variant analysis.
Genomic Data Management Platform
Consolidates genomic, clinical, and phenotypic data into a governed data layer - variant files, clinical annotations, and omic datasets unified on a shared identifier with role-based access, consent tracking, and immutable provenance records.
AI-Driven Variant Classification
ML-assisted ACMG/AMP classification - evidence aggregated from gnomAD, ClinVar, REVEL, CADD, SpliceAI, and internal lab history - surfaced with confidence scores and human-readable rationale so clinical teams review, verify, and sign off.
VUS Interpretation & Re-Analysis
VUS interpretation software with scheduled cohort-level re-analysis - automatic reclassification workflows triggered by evidence threshold changes, with notification to ordering clinicians on every reclassification event.
Cohort Querying & Analytics
Query across your entire variant dataset - cohort-level frequency, co-occurrence, phenotype correlation, and population stratification - using a genomics data lake architecture built for the scale and dimensionality of clinical variant repositories.
Multi-Omic Data Integration
Integrates WGS output, RNA-Seq expression data, proteomic profiles, and clinical phenotypes into a unified multi-omic data analysis layer - enabling cross-omic biomarker discovery and precision medicine programme analytics.
ML Model Training Infrastructure
Feature engineering pipelines, training environment on AWS SageMaker / GCP Vertex AI, experiment tracking with MLflow, and clinical deployment of pathogenicity prediction, tumour classification, and polygenic risk scoring models.
Explainable, Auditable, Clinically Trustworthy
Built on HIPAA-compliant genomic data infrastructure — VPC-isolated, KMS-encrypted, with immutable audit logs per classification event. Deployable on AWS, GCP, or Azure. Every AI output includes explainability metadata (SHAP values, evidence weights) so clinical teams never accept a classification on faith.
Data & AI Stack
- •Genomics data lake — Delta Lake, Apache Hail, Iceberg
- •ETL pipelines — dbt, Apache Spark, Athena / BigQuery
- •ML frameworks — scikit-learn, PyTorch, TensorFlow
- •Explainability — SHAP, attention weights, confidence scores
- •Model registry — MLflow, Weights & Biases
Compliance & Governance
- •HIPAA-compliant genomics data platform architecture
- •Role-based access with consent and PHI tracking
- •Immutable audit trail per variant classification event
- •Regulatory-aligned model cards and training provenance
- •AWS / GCP / Azure — all supported
Platforms That Feed Into and Build on the AI Analytics Platform
Bioinformatics Pipeline Platform
The upstream pipeline execution layer - producing the variant calls this platform classifies and re-analyses.
Built for Real Users
Empathy-driven delivery ensures solutions align with user behavior, team workflows, and measurable business outcomes.
Partnership, Not Projects
Long-term customer retention driven by consistent execution, reliability, and value beyond launch.
Frequently Asked Questions
Manual ACMG interpretation requires the interpreter to retrieve population frequency data, functional predictions, splice impact scores, literature citations, and internal lab history for every variant - a process that takes 15 to 45 minutes per variant depending on complexity. The AI-driven variant classification platform automates that evidence retrieval and aggregation, presenting the interpreter with a pre-assembled evidence dossier, a suggested ACMG classification tier, a confidence score, and the specific criteria that contributed to the suggestion. The interpreter reviews, adjusts if needed, and signs off. For high-volume labs running large gene panels or population-scale WGS programmes, this reduces interpretation time per variant by 60–70% while maintaining full clinical oversight and an auditable decision trail. VUS re-analysis runs automatically as new evidence accumulates - ensuring reclassification happens when the evidence supports it, not when someone remembers to check.
The automated variant interpretation platform aggregates evidence from population databases (gnomAD v2, v3, v4; 1000 Genomes; ClinVar), functional impact predictors (REVEL, CADD, SIFT, PolyPhen-2, AlphaMissense), splice prediction tools (SpliceAI, MaxEntScan), oncology-specific knowledge bases (OncoKB, CIViC, CGI, COSMIC Tier 1), and your lab's internal classification history - all surfaced at the variant level with source attribution. For precision medicine software development use cases, the platform also integrates phenotype data via HPO terms captured at order entry, enabling phenotype-driven variant prioritisation that surfaces the most clinically concordant variants before the interpreter opens the case.
Ready to Turn Your Variant Backlog into an Automated Interpretation Engine?
Tell us your PGx test menu, your EHR system, and your CDS alert requirements. We scope every PGx platform build to your clinical workflow.